isirv

About Guides FAQs

Font Size

SCREEN

Profile

Direction

Menu Style

Apply Reset  
In Brief
  1. ISIRV Journal: IRV Journal impact factor is now 4.4
  2. Abstract submission deadline for RSV2025 has been extended to 15 November.
13th International RSV Symposium (RSV2025)

  Return to Menu

 Abstract Submission                                        
 
 
Abstract submission is now closed - thank you
 
 
Abstracts of original research, for both oral and poster presentations, are positively encouraged. 
Abstract submission has been extended to 31 January 2019
      Categories:
Immunological Assays

Correlates of Protection

          Influenza Vaccines

Notification of acceptance will be sent by 4 February 2019

Publication: Upon submission of an abstract, the author provides consent to allow ISIRV to publish the abstract in the Programme/Abstract Book, and post on the ISIRV website.

Co-Author Approval: Please ensure that all co-authors approve of the abstract submission, publication, and potential presentation. Abstracts cannot be changed after 31 January 2019.

Author Disclosure: All abstract authors are required to disclose any conflict of interest.

Changes to Abstract: You are able to edit your abstract until the submission deadline. After the submission deadline, only minor abstract changes (author or institution changes, disclosure, keyword or questionnaire updates) are allowed. The deadline for minor updates and all withdrawals is the 9 January 2019. Any corrections, withdrawals and/or changes may not be accepted after this date.

 All enquiries to   isirvcoordination@gmail.com

ISIRV LTD - Registered Address: Office 7, 35-37 Ludgate Hill, London EC4M  7JN United Kingdom | Registered Company Number: 6021083 (England & Wales) | Registered Charity Number: 1118829